Trial
NCT03316729
DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Daiichi Sankyo
Collaborators
—
Condition
Pulmonary Embolism
Intervention
DS-9231
Why stopped
Product development cancelled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-24